Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Enliven Therapeutics Inc (ELVN)
Enliven Therapeutics Inc (ELVN) Financials

ELVN Enliven Therapeutics Inc

25.41

1.06 (4.35%)

28 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-294.276	-114.445	-79.294	-55.704	1.603	-39.351
Return on Equity (%)	86.161	-1804.846	-86.842	-60.287	1.689	-42.605
Return on Invested Capital (%)	-363.596	-148.146	-75.111	-60.448	-39.569	-50.769
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	8.366	2.804	4.812	3.273	3.429	5.967
Earnings Per Share	-16.15	-2.275	-2.805	-1.955	0.057	-1.737
Cash Per Share	10.516	0.479	2.718	1.838	3.355	2.43
Working Capital Per Share	8.366	2.563	4.796	3.252	3.34	5.83
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-16.15	-2.275	-2.357	-1.955	0.06	-1.737
EBITDA Per Share	-16.15	-2.275	-2.357	-1.955	0.06	-1.737
Free Cash Flow Per Share	-16.15	-2.265	-2.809	-1.958	0.047	-1.741

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	702k	10.31M	17.55M	26.29M	26.29M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	26.29M	26.29M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.19B
Price to Earnings Ratio	-4.31
Price to Sales Ratio	0
Price to Cash Ratio	3.08
Price to Book Ratio	1.26
Dividend Yield	-

Share Statistics

Shares Outstanding	48.86M
Average Volume (1 week)	199.76k
Average Volume (1 Month)	252.57k
52 Week Change	120.38%
52 Week High	30.03
52 Week Low	9.80

More Ratios Coming Soon!

Enliven Therapeutics

DCOJ28 - Abril 2028

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions